Downstream effectors of Akt, like mTORC1, MEK-ERK, and Src-ERK, have been associated with cholangiocarcinoma cells [87], induction of stemness markers [88], and amoeboid motility [89]. This evidence concerns the gene AKT1 and cholangiocarcinoma.